The menstrual cycle's impact on high performance female athletes' lived experiences training and perceptions of readiness to perform

Summary

This purpose of this study is to understand how the menstrual cycle impacts on high performance female athletes' lived experiences training and perceptions of readiness to perform through the use of 40-60 minute online interviews.The impact of the menstrual cycle (MC) on female athletes’ performance experiences and their perceived readiness to perform has not been studied. However, many studies have highlighted the need to consider a female athletes’ views on the MC and performance which may inform their training.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 35

Accepts healthy participants: Yes

Inclusion criteria:

1. high-performance female athlete
2. currently competing at or above the national level
3. willing to spend 40-60 min responding to an online semi-structured interview

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Paula Suarez Moreno (MSc. Student) email: paula.suarezmoreno@ucalgary.ca or cell-phone 1-403-402-1176

Principal investigator:

Patricia Katherine Doyle-Baker

Clinical trial:

No

REB-ID:

REB21-1573